Bio Protocol, a leading DeSci protocol, is set to host Token Generation Events (TGEs) for BiomeAI and eDMT on September 23, 2025, from 20:00 to 21:00 UTC+8, marking a milestone in tokenized biotech innovation. BiomeAI, focused on AI-driven microbiome health trials, achieved 6.4x oversubscription with $3.2M in $BIO pledges, while eDMT, exploring natural DMT production for brain health, hit 4.2x with $1.8M committed. Tokens become claimable and liquid on the Bio App, underscoring 2025 DeSci trends where blockchain funds decentralized research via fair-launch mechanisms.
What Is Bio Protocol in DeSci?
Bio Protocol is a blockchain-based platform for Decentralized Science (DeSci), enabling tokenized funding and IP monetization for biotech projects through BioDAOs and AI agents. Launched in early 2025 with a $6.9M seed round led by Maelstrom Fund, it uses $BIO staking to earn BioXP for launchpad access, fostering community-driven governance. The protocol's 2025 roadmap includes AI-managed DAOs for diseases like Long COVID, integrating wearables for on-chain health data. With over 6,100 participants pledging 5M+ $BIO, Bio Protocol bridges biotech with DeFi, targeting a $50M+ research funding ecosystem.
Core Utility: Stake $BIO for veBIO to vote and earn XP for fair allocations.
Launchpad Model: Ignition Sales reduce speculation via "jail" penalties for >50% sells.
Tokenomics: Fixed max supply, 39% initial circulation for stability.
Ecosystem Scale: 100+ BioAgents, pilots with Harvard for automated research.
BiomeAI TGE: AI for Gut Health Token Launch
BiomeAI, Bio Protocol's first microbiome-focused BioAgent, launches its $BIOMEAI token at a $200K initial FDV, projected to hit $1.16M post-TGE with 32x gains reported in early trading. Built on the N=10 model, it enables collaborative gut health experiments, logging lifestyles and trials for personalized insights from 1,000+ studies. Oversubscribed 6.4x with 3.2M $BIO from 6.1K users, tokens claim via Bio App with DEX liquidity. This TGE exemplifies DeSci's shift to agentic AI, where users stake $BIOMEAI for exclusive trial access, aligning with 2025's tokenized health data trends.
N=10 Innovation: Small-group trials for microbiome optimization.
Post-TGE Performance: $6.4M FDV, 32x surge on launch.
Staking Rewards: Holders access validated protocols and IP-NFTs.
Contract Address: 0x492AE2107F952b02f2554cE153841933c09d6d43 on Ethereum.
eDMT TGE: Psychedelics IP Token Debut
eDMT, an IP token for brain health via endogenous DMT research, TGEs at $400K FDV, eyeing $1M valuation with 10.5x gains. Oversubscribed 4.2x with 1.8M $BIO pledges, it tokenizes psychedelics studies for decentralized funding. Claimable on Bio App, eDMT integrates with BioDAOs for governance, minting IP-NFTs from experiments. As DeSci expands, eDMT addresses natural DMT production, appealing to wellness investors in 2025's neurotech boom.
Focus Area: Brain health via tokenized psychedelics IP.
Oversubscription: 4.2x, $4.2M post-TGE FDV.
Governance: Stake for DAO votes on research directions.
Bio Protocol's launchpad success, following Aubrai's 14.6x oversubscription, signals DeSci's maturation, funding $50M+ in biotech via on-chain transparency. With $BIO up 120% monthly, staking vs. yapping (social XP) strategies optimize participation, but "jeeters" face 3-week XP jails. Risks include volatility and verification timelines, yet AI agents like Aubrai's 1.5K insights demonstrate efficiency gains.
Market Sentiment: Positive X buzz on 32x/10.5x pumps despite tech glitches.
Roadmap Highlights: V2 Q4 with multi-chain, wet-lab integrations.
Risks: Early-stage outputs need validation; focus on long-term ecosystem.
Adoption Metrics: $10M+ TVL, Asia pilots expanding reach.
In summary, Bio Protocol's BiomeAI and eDMT TGEs propel DeSci forward in 2025, blending AI, biotech, and blockchain for tokenized innovation. Stake $BIO on compliant platforms for XP, and monitor Bio App for claims—explore DeSci resources for secure, educational entry into this high-potential sector.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Bio Protocol TGEs: BiomeAI and eDMT Launch with 6.4x and 4.2x Oversubscription in DeSci Boom
Bio Protocol, a leading DeSci protocol, is set to host Token Generation Events (TGEs) for BiomeAI and eDMT on September 23, 2025, from 20:00 to 21:00 UTC+8, marking a milestone in tokenized biotech innovation. BiomeAI, focused on AI-driven microbiome health trials, achieved 6.4x oversubscription with $3.2M in $BIO pledges, while eDMT, exploring natural DMT production for brain health, hit 4.2x with $1.8M committed. Tokens become claimable and liquid on the Bio App, underscoring 2025 DeSci trends where blockchain funds decentralized research via fair-launch mechanisms.
What Is Bio Protocol in DeSci?
Bio Protocol is a blockchain-based platform for Decentralized Science (DeSci), enabling tokenized funding and IP monetization for biotech projects through BioDAOs and AI agents. Launched in early 2025 with a $6.9M seed round led by Maelstrom Fund, it uses $BIO staking to earn BioXP for launchpad access, fostering community-driven governance. The protocol's 2025 roadmap includes AI-managed DAOs for diseases like Long COVID, integrating wearables for on-chain health data. With over 6,100 participants pledging 5M+ $BIO, Bio Protocol bridges biotech with DeFi, targeting a $50M+ research funding ecosystem.
BiomeAI TGE: AI for Gut Health Token Launch
BiomeAI, Bio Protocol's first microbiome-focused BioAgent, launches its $BIOMEAI token at a $200K initial FDV, projected to hit $1.16M post-TGE with 32x gains reported in early trading. Built on the N=10 model, it enables collaborative gut health experiments, logging lifestyles and trials for personalized insights from 1,000+ studies. Oversubscribed 6.4x with 3.2M $BIO from 6.1K users, tokens claim via Bio App with DEX liquidity. This TGE exemplifies DeSci's shift to agentic AI, where users stake $BIOMEAI for exclusive trial access, aligning with 2025's tokenized health data trends.
eDMT TGE: Psychedelics IP Token Debut
eDMT, an IP token for brain health via endogenous DMT research, TGEs at $400K FDV, eyeing $1M valuation with 10.5x gains. Oversubscribed 4.2x with 1.8M $BIO pledges, it tokenizes psychedelics studies for decentralized funding. Claimable on Bio App, eDMT integrates with BioDAOs for governance, minting IP-NFTs from experiments. As DeSci expands, eDMT addresses natural DMT production, appealing to wellness investors in 2025's neurotech boom.
DeSci Trends and Bio Protocol's Role
Bio Protocol's launchpad success, following Aubrai's 14.6x oversubscription, signals DeSci's maturation, funding $50M+ in biotech via on-chain transparency. With $BIO up 120% monthly, staking vs. yapping (social XP) strategies optimize participation, but "jeeters" face 3-week XP jails. Risks include volatility and verification timelines, yet AI agents like Aubrai's 1.5K insights demonstrate efficiency gains.
In summary, Bio Protocol's BiomeAI and eDMT TGEs propel DeSci forward in 2025, blending AI, biotech, and blockchain for tokenized innovation. Stake $BIO on compliant platforms for XP, and monitor Bio App for claims—explore DeSci resources for secure, educational entry into this high-potential sector.